Global Vascular Boot Market Size, and Share, By Product (Intermittent Pneumatic Compression Boots, Cold Therapy Vascular Boots, and Combined Therapy Vascular Boots), By Application (Deep Vein Thrombosis Prevention, Lymphedema Management, Sports Injury Recovery, and Circulatory Disorders), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Vascular Boot Market Insights Forecasts to 2035

• The Global Vascular Boot Market Size Was Estimated at USD 1.15 Billion in 2025
• The Market Size is Expected to Grow at a CAGR of around 3.36% from 2025 to 2035
• The Worldwide Vascular Boot Market Size is Expected to Reach USD 1.60 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global vascular boot market size was worth around USD 1.15 billion in 2025 and is predicted to grow to around USD 1.60 billion by 2035 with a compound annual growth rate (CAGR) of 3.36% from 2025 to 2035.

Market Overview

The global sector that includes the production, marketing, and distribution of specialist medical equipment called vascular boots is referred to as the "vascular boot market." In patients with peripheral vascular disease, venous insufficiency, deep vein thrombosis (DVT), lymphedema, or post-surgical immobility, these therapeutic footwear or leg enclosures are intended to enhance lower-extremity circulation, prevent pressure ulcers, particularly heel ulcers, lessen edema, and promote wound healing. According to regulatory frameworks such as FDA 510(k), these devices are categorized as Class I/II medical devices or durable medical equipment (DME).

In June 2025, the Technology Development Board launched financial support for S3V Vascular Technologies to develop India’s first indigenous mechanical thrombectomy system, marking a breakthrough in stroke intervention technology and strengthening the country’s domestic medical device manufacturing capabilities. The growing incidence of peripheral vascular conditions such as deep vein thrombosis and chronic venous insufficiency, which call for efficient treatment options, is the main factor propelling the vascular boot industry. The market demand is further accelerated by the aging population, which is increasingly prone to circulatory problems. 

Report Coverage

This research report categorizes the vascular boot market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the vascular boot market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the vascular boot market.   

Driving Factors

Vascular boots are becoming more popular in both clinical and home care settings due to increased awareness of early diagnosis and preventative healthcare practices. Treatment effectiveness and patient compliance are being improved by technological developments such as better compression systems and user-friendly designs. Furthermore, increased access to cutting-edge medical technologies is being made possible by the development of healthcare infrastructure, especially in developing nations. The growing inclination for non-invasive treatment approaches and favorable reimbursement policies in developed areas also play a major role in the market's expansion. Additionally, the growing prevalence of lifestyle-related diseases, including diabetes and obesity, is driving up demand for vascular boot treatments globally.

Restraining Factors

High device costs, little awareness in developing nations, strict regulatory clearances, the possibility of incorrect use, and the availability of alternative therapies all restrict the vascular boot market's expansion and general use in healthcare settings.    

Market Segmentation        

The vascular boot market share is classified into product and application.    

• The intermittent pneumatic compression boots segment dominated the market in 2025, approximately 58%, and is projected to grow at a substantial CAGR during the forecast period.   

Based on the product, the vascular boot market is divided into intermittent pneumatic compression boots, cold therapy vascular boots, and combined therapy vascular boots. Among these, the intermittent pneumatic compression boots segment dominated the market in 2025, approximately 58%, and is projected to grow at a substantial CAGR during the forecast period. The great clinical efficacy of intermittent pneumatic compression boots in enhancing blood circulation and preventing deep vein thrombosis accounts for the section. Hospitals, surgical recovery units, and homecare settings frequently use these devices, especially for patients who are immobile and recovering from surgery. Their capacity to deliver sequential, regulated compression improves venous return and lowers the chance of clot formation.     

• The deep vein thrombosis prevention segment accounted for the highest market revenue in 2025, approximately 54%, and is anticipated to grow at a significant CAGR during the forecast period.         

Based on the application, the vascular boot market is divided into deep vein thrombosis prevention, lymphedema management, sports injury recovery, and circulatory disorders. Among these are the deep vein thrombosis prevention segment accounted for the highest market revenue in 2025, approximately 54%, and is anticipated to grow at a significant CAGR during the forecast period. The section on deep vein thrombosis prevention is important because it helps prevent potentially fatal blood clots, especially in hospitalized and surgical patients. In order to improve blood circulation and lower the risk of clot formation, vascular boots are frequently used in orthopedic procedures, intensive care units, and instances involving prolonged immobility.  

Regional Segment Analysis of the Vascular Boot Market  

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the vascular boot market over the predicted timeframe.      

North America is anticipated to hold the largest share of the vascular boot market over the predicted timeframe. North America's highly developed healthcare system and early adoption of cutting-edge medical technologies are the primary explanations for this. The demand for vascular boot devices is greatly influenced by the high frequency of vascular conditions in the area, including peripheral artery disease, deep vein thrombosis, and chronic venous insufficiency. In order to reduce DVT in hospitals and outpatient settings, DJO Global (Enovis) introduced an upgraded pneumatic compression system with improved connection in 2026. Mölnlycke included integrated compression-wound care products to its lineup. For personalized IPC treatment, Cardinal Health unveiled the Kendall SCD SmartFlow system.

Asia Pacific is expected to grow at a rapid CAGR in the vascular boot market during the forecast period. Significant advancements in healthcare infrastructure and rising healthcare investments in developing nations like China and India are driving the Asia Pacific region. A sizable patient population in need of vascular treatments is being created by the increasing frequency of chronic illnesses, including diabetes and cardiovascular problems. Several APAC governments are encouraging venous disease prevention initiatives and updating healthcare infrastructure. Hospital-acquired pressure injuries and diabetes-related complications are the focus of public health efforts in China and India.     

Competitive Analysis:   

The report offers the appropriate analysis of the key organizations/companies involved within the vascular boot market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

List of Key Companies

• Action Products, Inc.
• Cardinal Health, Inc.
• ConvaTec Group Plc
• DARCO International, Inc.
• DJO Global (Enovis)
• Drive DeVilbiss Healthcare
• EHOB, Inc.
• Medline Industries, LP
• Mölnlycke Health Care AB
• Össur hf.
• Skil-Care Corporation
• Span-America Medical Systems
• Therafin Corporation
• 3M Company
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the vascular boot market based on the below-mentioned segments: 

Global Vascular Boot Market, By Product  

• Intermittent Pneumatic Compression Boots
• Cold Therapy Vascular Boots
• Combined Therapy Vascular Boots

Global Vascular Boot Market, By Application

• Deep Vein Thrombosis Prevention
• Lymphedema Management
• Sports Injury Recovery
• Circulatory Disorders

Global Vascular Boot Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa